Already a hated pricing foe, Germany eyes stiff new controls by Tracy Staton Monday, November 14, 2016 In another sign of pharma's dwindling pricing power, Germany is on the verge of stiffening up its already strict drug pricing rules, a move that could prompt more Big Pharma companies to pull products off that market.
